EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 323 filers reported holding EXELIXIS INC in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $889,000 | -35.6% | 51,600 | -34.1% | 0.09% | +13.9% |
Q4 2019 | $1,381,000 | -0.7% | 78,355 | -0.4% | 0.08% | +19.7% |
Q3 2019 | $1,391,000 | +99.6% | 78,665 | +141.3% | 0.07% | +112.9% |
Q2 2019 | $697,000 | -32.3% | 32,600 | -37.7% | 0.03% | -26.2% |
Q4 2018 | $1,030,000 | +13.3% | 52,360 | +2.0% | 0.04% | +55.6% |
Q3 2018 | $909,000 | -24.2% | 51,315 | -7.9% | 0.03% | -27.0% |
Q2 2018 | $1,199,000 | +16.0% | 55,710 | +19.3% | 0.04% | +12.1% |
Q1 2018 | $1,034,000 | -82.7% | 46,700 | -76.3% | 0.03% | -82.0% |
Q4 2017 | $5,984,000 | +37.0% | 196,850 | +9.2% | 0.18% | +32.6% |
Q3 2017 | $4,369,000 | +75.3% | 180,295 | +78.2% | 0.14% | +106.0% |
Q2 2017 | $2,492,000 | -28.8% | 101,180 | -37.3% | 0.07% | -33.0% |
Q1 2017 | $3,499,000 | +40.0% | 161,480 | -3.7% | 0.10% | +51.5% |
Q4 2016 | $2,499,000 | -15.9% | 167,630 | -27.9% | 0.07% | -19.5% |
Q3 2016 | $2,972,000 | – | 232,390 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |